Back

Sex-based disparities in early complications following cardiac implantable electronic device implantation: a nationwide analysis

28 August 2026 (10:55 - 11:05)
Organised by: Logo
Congress Presentation Part of: Infective endocarditis: incidence and management Cardiac Implantable Device-Related Endocarditis ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Sultana Jahan

Valley Health System LLC, Las Vegas (United States of America)

5 More presentations in this session

Presentation thumbnail
Cost reduction with partial step-down oral antibiotic endocarditis treatment (POET)
Doctor N. Kader (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Long-term incidence of infective endocarditis according to the type of cardiac implantable electronic device: a nationwide comparison with moderate- and high-risk patient groups
Doctor A. Alhakak (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Transthoracic echocardiography in assessing patients with suspected endocarditis (TEASE-Forward Study): a prospective cohort study
Doctor A. Marino (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Risk of endocarditis after transcatheter aortic valve implantation (TAVI) in patients under hemodialysis
Professor M. Moeckel (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Patient characteristics, procedural features and outcomes of percutaneous aspiration of large vegetations in patients with infective endocarditis
Mrs P. Savvinova (Leipzig, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Infective endocarditis: incidence and management
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 10:55 CET
You may be interested in
thumbnail
Congress Session
Latest science in ICD and sudden cardiac death
28 August 2022
thumbnail
Congress Presentation
Gender differences in transcatheter aortic valve replacement per-procedural complications and 1 year mortality
31 August 2025
thumbnail
Congress Presentation
Sex differences in indications, complications and outcomes of de novo implantable cardioverter defibrillator and cardiac resynchronization therapy: with a focus on diabetes status
31 August 2025
thumbnail
Congress Presentation
Impact of sepsis on morbidity and mortality in patients with cardiac implantable electronic devices: real-world data from a high-volume center
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources